Insider Trading Alert - IT, MMS And AVA Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 20, 2014, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $712.40 to $14,201,355.08.

Highlighted Stocks Traded by Insiders:

Gartner (IT) - FREE Research Report

Kranich Robin B, who is SVP, Human Resources at Gartner, sold 17,317 shares at $73.17 on Aug. 20, 2014. Following this transaction, the SVP, Human Resources owned 8,775 shares meaning that the stake was reduced by 66.37% with the 17,317-share transaction.

The shares most recently traded at $73.74, up $0.57, or 0.78% since the insider transaction. Historical insider transactions for Gartner go as follows:

  • 4-Week # shares sold: 13,158
  • 12-Week # shares sold: 66,492
  • 24-Week # shares sold: 82,217

The average volume for Gartner has been 375,400 shares per day over the past 30 days. Gartner has a market cap of $6.6 billion and is part of the technology sector and computer software & services industry. Shares are up 3.72% year-to-date as of the close of trading on Wednesday.

Gartner, Inc. provides independent and objective research and analysis on the information technology (IT), computer hardware, software, communications, and related technology industries in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company has a P/E ratio of 36.0. Currently, there are 4 analysts who rate Gartner a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IT - FREE

TheStreet Quant Ratings rates Gartner as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Gartner Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Maximus (MMS) - FREE Research Report

Montoni Richard A, who is Ceo at Maximus, sold 25,000 shares at $40.04 on Aug. 20, 2014. Following this transaction, the Ceo owned 601,200 shares meaning that the stake was reduced by 3.99% with the 25,000-share transaction.

The shares most recently traded at $41.52, up $1.48, or 3.55% since the insider transaction. Historical insider transactions for Maximus go as follows:

  • 4-Week # shares bought: 245
  • 4-Week # shares sold: 2,806
  • 12-Week # shares bought: 245
  • 12-Week # shares sold: 9,418
  • 24-Week # shares bought: 245
  • 24-Week # shares sold: 66,507

The average volume for Maximus has been 367,500 shares per day over the past 30 days. Maximus has a market cap of $2.8 billion and is part of the services sector and diversified services industry. Shares are down 5.64% year-to-date as of the close of trading on Wednesday.

MAXIMUS, Inc. provides business process services to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company operates in two segments, Health Services and Human Services. The stock currently has a dividend yield of 0.43%. The company has a P/E ratio of 19.9. Currently, there are 3 analysts who rate Maximus a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMS - FREE

TheStreet Quant Ratings rates Maximus as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Maximus Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Avista (AVA) - FREE Research Report

Kensok James M, who is Vice President at Avista, sold 350 shares at $31.83 on Aug. 20, 2014. Following this transaction, the Vice President owned 9,543 shares meaning that the stake was reduced by 3.54% with the 350-share transaction.

The shares most recently traded at $32.02, up $0.19, or 0.59% since the insider transaction. Historical insider transactions for Avista go as follows:

  • 4-Week # shares sold: 2,200
  • 12-Week # shares sold: 7,516
  • 24-Week # shares sold: 7,516

The average volume for Avista has been 345,600 shares per day over the past 30 days. Avista has a market cap of $2.1 billion and is part of the utilities sector and utilities industry. Shares are up 13.41% year-to-date as of the close of trading on Wednesday.

Avista Corporation, an energy company, is engaged in the generation, transmission, and distribution of electricity; and distribution of natural gas primarily in the United States and Canada. It operates in two segments, Avista Utilities and Ecova. The stock currently has a dividend yield of 3.97%. The company has a P/E ratio of 15.5. Currently, there are no analysts who rate Avista a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AVA - FREE

TheStreet Quant Ratings rates Avista as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Avista Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists